Skip to search formSkip to main contentSkip to account menu

Salicylamides

Known as: Salicylamides [Chemical/Ingredient] 
Amides of salicylic acid.
National Institutes of Health

Related topics

Related topics

30 relations

Narrower (24)

3-iodo-4-azido-N-hexadecylsalicylamideFLA 797FLB 457FLB 463
In Bloodagonistsantagonists & inhibitorsaspects of radiation effects

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Hybrids of Salicylalkylamides and Mannich Bases: Control of the Amide Conformation by Hydrogen Bonding in Solution and in the Solid State
3-Aminomethylation of salicylalkylamides afforded hybrids with a Mannich base. In addition, it triggered the rotation of the… 
2012
2012
Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC-EGFR dual inhibitors.
Highly Cited
2009
Highly Cited
2009
Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
A number of potential neuroleptic drugs of the substituted benzamide type have been compared with some reference neuroleptic… 
2001
2001
Synthesis and evaluation of the analgesic and antiinflammatory activities of O-substituted salicylamides.
The present investigation deals with the synthesis of some new salicylamidoacetyl sulfonamides 3a,b, salicylamido ethylacetate 4… 
1994
1994
Salicylamides Containing Amino Acid or Pyran Moieties with Molluscicidal Activity
Salicylamide amino acid conjugates were prepared utilizing 5‐formyl‐, 5‐dicyanoethenyl‐, and 5‐nitroethenylsalicylic acid. 5… 
1990
1990
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds.
A series of 3-substituted 5,6-dimethoxysalicylamides III (9-13 and 15) has been synthesized from the corresponding 2,5,6… 
1987
1987
Crystallographic, theoretical and molecular modelling studies on the conformations of the salicylamide, raclopride, a selective dopamine‐D2 antagonist *
The structure of the potent dopamine‐D2 antagonist, raclopride, (S)‐3,5‐dichloro‐N‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]‐6… 
Highly Cited
1986
Highly Cited
1986
Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
A series of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl) methyl]-6-methoxysalicylamides was synthesized, starting from the 2,6… 
Highly Cited
1984
Highly Cited
1984
Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs:study of additional 34 drugs.
Highly Cited
1982
Highly Cited
1982
Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
A series of phenethanolamines (3) based on salicylamide has been prepared and shown to possess beta-adrenergic blocking… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)